Natera
An Associate Director of Oncology Lifecycle Management for Hematologic Malignancies at Natera focuses on shaping strategic direction and driving execution for company success in Hematologic Oncology, with responsibilities including product launch, market access, KOL engagement, and strategic planning.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Right around the average for this role
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Thought Leader Liaison, Hematologic Oncology, Mid-Atlantic
Sanofi
Director, Medical Affairs - Oncology and Hematologic Malignancies
Labcorp
Thought Leader Liaison US Hematologic Oncology and Transplant Midwest
Sanofi
Thought Leader Liaison, U.S. Hematologic Oncology and Transplant
Sanofi
R2872825 Thought Leader Liaison U.S. Hematologic Oncology and Transplant TX OK AR
Sanofi
Director of Pediatric Hematologic Malignancies
Johns Hopkins University